Börsipäev 23. juuni
Postitusi kokku 3
Nelli_Janson

Head Võidupüha kõigile LHV foorumlastele.<br/><br/>Pühade tõttu on täna suletud nii Tallinna kui Läti börs, aga USA ja Euroopa turud on ikka avatud tavapärasel ajal.<br/>Peale eilset jõulist rallit Kreeka päästeplaani õnnestumise lootuses on USA- s natuke hinge tõmmatud ja futuurid kauplevad sisuliselt muutusteta. <br/>Kuigi võlausaldajad tervitasid Kreeka valmidust oma probleemidele lahendus leida, siis nüüd on teada, et Euroopa liidrid on Kreekale andnud 48h aega, et oma päästeplaani nö vastuvõetavamaks kohendada.<br/>USA-s teatati ka mai kestvuskaupade tellimused, mis langesid 1,8% ja seda peamiselt tellimuste järsu languse tõttu lenndundussektoris. Näiteks Boeing teatas 28,9%-st müügilangusest. <br/>Samas elektrooniliste toodete tellimused kasvasid 2,2%.<br/>Veel on jooksnud läbi Jerome Powelli (Fed) kommentaar, kus ta viitab soodsale keskkonnale intressitõsteks septembris. Tasub märkida, et ta on olnud siiani intressitõste teemal pigem ettevaatlikul seisukohal.

Nelli_Janson

<b>Gapping up<br/>In reaction to strong earnings/guidance:</b> BBRY +8.3%, DRI +6.7%<br/><br/><b>M&amp;A news:</b> EXXI +3.6% (confirmed sale of its Grand Isle Gathering System to CorEnergy Infrastructure Trust (CORR) for $245 mln), SYT +0.5% (Chairman reaffirms stance regarding Monsanta (MON) takeover offer in video interview; states MON trying to buy the co on the cheap)<br/><br/><b>Select EU related names showing cont strength:</b> ALV +2.4%, SHPG +1.9%, SNY +1.5%, UN +1.2%, ALU +1%<br/><br/><b>Other news: </b>GDOT +30.6% (announced 5-year agreement with Walmart (WMT) and $150 mln stock buyback), PHMD +19% (announces the sale of its worldwide XTRAC and VTRAC psoriasis and vitiligo treatment businesses to MELA Sciences (MELA) for $42.5 mln in cash (MELA) shares halted) ), AMRN +15.6% (will present new in vitro eicosapentaenoic acid study data; found that EPA reduced cholesterol crystalline domain levels in cholesterol-enriched model membranes by 65%will present new in vitro eicosapentaenoic acid study data; found that EPA reduced cholesterol crystalline domain levels in cholesterol-enriched model membranes by 65%), BIND +7.5% (FDA authorizes clinical trial with AstraZeneca&#39;s (AZN) Aurora B kinase inhibitor), WAC +4.3% (Baker Street Capital disclosed 22.3% active stake in 13D filing), SGYP +4% (initiates a second Phase 3 clinical trial of Plecanatide), KEG +3.5% (named Robert Drummond President and COO)), NBG +3.1% (optimism of Greece deal in coming days), AMBA +3% (modest strength following yday&#39;s sell off), QURE +2.3% (Bristol-Myers Squibb discloses 4.9% passive stake in 13G filing; stake to rise to 9.9% upon future purchases required under agreement between the companies), MDR +2.2% (awarded a lump sum contract by LLOG Exploration Offshore, for services in the Gulf of Mexico), APPY +1.2% (to host an investor conference call to provide an update on regulatory and business matters, on Wednesday, June 24, 2015, at 4:30 p.m. ET), KRFT +1% (declares special cash dividend of $16.50 per share, conditioned upon closing of proposed merger with Heinz ), HZNP +1% (USPTO issues an additional notice of allowance with claims covering Ravicti oral liquid), RDUS +0.9% (favorable commentary on Monday&#39;s Mad Money), NSPH +0.8% (announced the presentation of new studies highlighting antibiotic resistance detection with its verigene blood culture tests), VIMC +0.8% (receives $22 mln contract for the provision of SVAC-compliant video surveillance cameras and system to Jincheng Municipal Government in Shanxi Province)<br/><br/><b>Analyst comments:</b> CASI +6.6% (initiated with a Buy at H.C. Wainwright; tgt $2.50), LPCN +3.1% (initiated with a Buy at Canaccord Genuity; $15 tgt), DEO +2.3% (upgraded to Buy from Neutral at Nomura), T +1.6% (upgraded to Overweight from Equal Weight at Barclays; upgraded to Buy from Neutral at UBS), VOD +1.5% (upgraded to Buy from Neutral at Nomura), YELP +1.4% (initiated with a Buy at Topeka Capital Markets ), PRGO +1.2% (initiated with an Outperform at BMO Capital), CI +0.9% (target raised to $175 from $160 at Leerink Partners), JBLU +0.9% (upgraded to Equal-Weight from Underweight at Morgan Stanley), DAL +0.9% (assumed with a Overweight at Morgan Stanley), IHG +0.9% (upgraded to Outperform at Credit Suisse), SNN +0.6% (upgraded to Buy from Neutral at UBS), GG +0.6% (upgraded to Action List Buy at TD Securities; $29 tgt)<br/><br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance: </b>SONC -5.8%<br/><br/><b>M&amp;A news: </b>CTP -91.3% (announce negotiations with DHR International regarding an acquisition of the co expired with no definitive agreement for the sale of the co having been reached), CORR -3.4% (to acquire the Grand Isle Gathering System for $245 mln from Energy XXI (EXXI); announced 11.25 mln share offering of common stock; increased quarterly dividend to $0.60 from $0.54 per share)<br/><br/><b>Select metals/mining stocks trading lower: </b>HMY -4.3%, GFI -1.9%, SLV -1.2%, GOLD -1%, SLW -0.8%<br/><br/><b><br/>Other news: </b>VICL -48.6% (reported top-line results from the Phase 1/2 trial of its therapeutic genital herpes vaccine; neither monovalent nor bivalent vaccine met the primary endpoint), GLOP -8% (announced acquisition of three vessels from GasLog (GLOG) for $483 mln; announced a public offering of 7.5 mln common units), AXN -7.2% (filed for $50 mln mixed securities shelf offering), WSR -4.7% (to make a public offering of 3.75 mln of its common shares), TGEN -2.2% (filed for ~3.72 mln share common stock offering), XL -1.6% (reports of a 5 mln share block trade in the stock), GRBK -1.2% (announced proposed offering of 17 mln shares of common stock), VTG -1.2% (co announced it has retained Lazard to assist in review of financing and strategic opportunities)<br/> <br/>Allikas: Briefing.com

Nelli_Janson

<i>Seeing headlines that heads of the Troika (ECB, EU, and IMF) set to meet Wednesday ahead of the EU Leaders Summit on Thursday</i>